Support Alert

Class 4 medicines defect information: Generics [UK] Limited t/a Mylan perindopril erbumine tablets

Generics [UK] Limited t/a Mylan has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that there is missing relevant important safety information in the Patient Information Leaflet (PIL) affecting various strengths and batches of perindopril erbumine tablets.

Further information including details of the affected products and batches, a brief description of the problem, details of the missing information and advice for healthcare professionals can be found on the MHRA website.